- Federico Pignatelli resigns as Chairman and CEO of Biolase (NASDAQ:BIOL) subsequent to the June 12 ruling from the Delaware Supreme Court. He will continue as a member of the BOD along with Paul Clark, Dr. Fred Moll, Dr. Norman Nemoy, Jim Talevich and Jeff Nugent.
- Mr. Clark is elected Chairman of the Board. He was formerly the CEO of ICOS. Before that, he was President of Abbott's Pharmaceutical Division.
- Mr. Nugent will serve as interim CEO until a permanent Chief Executive is appointed.
Pignatelli out at Biolase
Recommended For You
About BIOL Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
BIOL | - | - |
BIOLASE, Inc. |